Eisler Capital (Uk) Ltd. Vertex Pharmaceuticals Inc Put Options Transaction History

Eisler Capital (Uk) Ltd.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $33.2 Million - $36.6 Million	-72,269 Reduced 70.21%	30,662 $14.3 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $29.5 Million - $36.4 Million	75,049 Added 269.17%	102,931 $48.2 Million
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $5.65 Million - $6.18 Million	13,852 Added 98.73%	27,882 $11.7 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $4.17 Million - $4.99 Million	12,144 Added 643.9%	14,030 $5.71 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $637,807 - $683,599	1,886 New	1,886 $655,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.